Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
With the opening of a new UK & Ireland headquarters last month, Intuitive Surgical is aiming to strengthen its grip on the the market as it faces increasing competition in the robotic surgery space. CEO Gary Guthart sat down with Medtech Insight at its new Oxfordshire, UK HQ to discuss expansion and innovation plans.
Latest From Companies
With the US FDA urging providers to transition away from fixed duodenoscopes to newer designs that reduce or eliminate reprocessing of the device, Pentax Medical is seizing an opportunity to increase supply of its disposable cap scope. Medtech Insight talks to the company’s global clinical officer, Garrett Hudson, on the challenges of endoscopy hygiene and the company’s response to guidance.
Qiagen shares took a hit following a series of negative announcements, including lower than expected results for Q3 2019 and the departure of long-term CEO Peer Schatz. The company said it had been affected by poor sales growth in China.
Israeli healthtech fund Accelmed is raising $100m for its fourth fund focused on medical device and digital health companies.
In October, health IT startup LifePod will debut its proactive voice-assistant device for caregivers to help improve care of the elderly. The device differs from other voice services by including a proactive dialogue to remind the aging person of appointments, events and medications, and gives caregivers real-time feedback on how well patients are doing.
The winners of this year’s Medtech Insight Awards were revealed last night at a glittery ceremony in Boston. The awards, held in partnership with the MedTech Conference, recognized excellence and achievement across the industry.
In this edition of Device Week, Medtech Insight’s Catherine Longworth chats to Marion Webb about two new major partnerships signed in the diabetes sector, and finds out more about ResMed’s growth strategy.
Tel-Aviv, Isreal-based DreaMed Diabetes received another US Food and Drug Administration clearance for its AI-powered Advisor Pro software, which helps providers manage and optimize treatment for patients with type 1 diabetes. See what DreaMed's CEO, Eran Atlas, said about it here.
Israeli firm DreaMed has scored a new US Food and Drug Administration clearance for its AI-based diabetes decision support system Advisor Pro. The clearance enables physicians to use the software for patients with type 1 diabetes using continuous glucose monitoring (CGMs) and blood glucose meters (BGMs).
UK robotics firm CMR Surgical has landed $240m from investors as it prepares to launch its robotic surgery system in Europe and India. The Series C raise is Europe’s largest private financing round in the medical technology sector to date.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.